Santen Pharmaceutical Co Ltd (4536) – Strategy, SWOT and Corporate Finance Report
- Pages: 63
- Published: June 2023
- Report Code: MLPH6375FSA
Santen Pharmaceutical Co Ltd (4536) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacturing and marketing of pharmaceutical products and medical devices. Its product portfolio includes prescription ophthalmic products for glaucoma, bacterial conjunctivitis, dry eye, inflammation, cataract, muscae volitantes, diabetic retinopathy, retinal detachment, hyposphagma, myopia, retinal detachment, amblyopia, astigmatism, strabismus, hordeolum, VDT syndrome, and others; over-the-counter products ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and other ophthalmic products. Santen operates through its group companies located in Asia, Europe and the US. It operates production facilities in Noto, and Shiga, Japan; and Suzhou, China. Santen is headquartered in Kita-ku, Osaka, Japan.
Scope
• Detailed information on Santen Pharmaceutical Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Santen Pharmaceutical Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Santen Pharmaceutical Co Ltd including a breakdown and examination of key business segments
• News about Santen Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Santen Pharmaceutical Co Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Santen Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Santen Pharmaceutical Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Rohto Pharmaceutical Co Ltd
Senju Pharmaceutical Co Ltd
Astellas Pharma Inc
Aqumen Biopharmaceuticals
Mitsubishi Tanabe Pharma Corp
Chugai Pharmaceutical Co Ltd
Taisho Pharmaceutical Holdings Co Ltd
Daiichi Sankyo Co Ltd
Hoya Corp
Mitsubishi Tanabe Pharma Corp
Astellas Pharma Inc
Aqumen Biopharmaceuticals
Alcon Japan Ltd
Daiichi Sankyo Co Ltd
Hoya Corp
Rohto Pharmaceutical Co Ltd
Senju Pharmaceutical Co Ltd
Chugai Pharmaceutical Co Ltd
Taisho Pharmaceutical Holdings Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.